Expert Insights On Downstream Bioprocessing
-
TFF Offers Ideal Anaerobic, GMP Conditions For LBP Concentration
12/8/2025
When configured correctly, TFF provides the gentle processing environment and oxygen protection required for strict anaerobes.
-
Strained Manufacturing, Complexity Stymie In Vivo Progress
12/4/2025
Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.
-
Dual Membrane Preconditioning Can Improve Concentration, Cut HCPs
10/27/2025
Research from Penn State, the FDA, and Takeda shows how combination filtration and purification steps improve output and reduce impurities.
-
Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms
10/22/2025
The company developed a novel approach to address the historic lack of stability testing for underserved parts of the world, near the equator.
-
Survey: 30% Of Biopharmas Cite Cost, Productivity As Top Priorities
10/6/2025
Both focus areas aim at the same outcome, stronger economics and sustainable competitiveness, according to BioPlan Associates' 22nd Annual Biomanufacturing Report.
-
Unlocking Method Insights For Novel Engineered AAV Capsids
9/18/2025
Microfluidic platforms, such as labchip, are widely used for assessing wild type capsids. Now, engineered capsids are challenging these established workflows.
-
How AbbVie's Digital Transformation Brought Platform Knowledge Closer
9/9/2025
A custom-built digital ecosystem reduced the time spent on documentation in AbbVie's bioprocess development labs by about 70% for some experiment types.
-
A Case Study In Continuous Process Verification
9/8/2025
CPV can strengthen the bridge between compliance and continuous improvement. In this scenario, a hypothetical lab sets out to improve process yields and efficiency.
-
Optimizing Lentiviral Vectors For Allogeneic CAR-T Manufacturing
9/5/2025
A group of graduate researchers explored VSV-G affinity chromatography as an alternative to the standard anion exchange chromatography or AEX.
-
Lilly's Exploring A Universal AAV Purification Method
9/2/2025
Serotype-specific resins don't scale gracefully. One team at Eli Lilly and Company is exploring an alternative that skips affinity resins altogether.